Ampac Fine Chemicals Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is REMIFENTANIL HYDROCHLORIDE, with a corresponding US DMF Number 34303.
Remarkably, this DMF maintains an Active status since its submission on November 18, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 14, 2021, and payment made on February 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II